These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4196972)

  • 21. Glucose tolerance in diabetes mellitus during treatment with the sulfonylurea hypoglycemic agents.
    Herman JB
    Isr J Med Sci; 1966; 2(6):733-7. PubMed ID: 5956689
    [No Abstract]   [Full Text] [Related]  

  • 22. Glibenclamide is exceptional among hypoglycaemic sulphonylureas in accumulating progressively in beta-cell-rich pancreatic islets.
    Hellman B; Sehlin J; Täljedal IB
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):385-90. PubMed ID: 6230850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ON TOLAZAMIDE: APROPOS OF A NEW HYPOGLYCEMIC SULFANYLUREA AND OF ACQUIRED SULFANYLUREAU RESISTANCE].
    KLINGER R; DALLECOSTE P
    Minerva Med; 1964 Jul; 55():2237-40. PubMed ID: 14179829
    [No Abstract]   [Full Text] [Related]  

  • 24. [Attempted suicide with bucarban].
    Szegedi G; Wórum F
    Orv Hetil; 1966 Mar; 107(13):604-5. PubMed ID: 5930415
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum insulin values in hypoglycemic shock during suicide attempts with tolbutamide and insuline].
    Creutzfeldt W; Frerichs H; Perings E
    Dtsch Med Wochenschr; 1968 Apr; 93(17):856-60. PubMed ID: 5646124
    [No Abstract]   [Full Text] [Related]  

  • 26. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 27. Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.
    Heine P; Kewitz H; Schnapperelle U
    Eur J Clin Pharmacol; 1974 Aug; 7(5):321-30. PubMed ID: 4213593
    [No Abstract]   [Full Text] [Related]  

  • 28. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
    Hausmann L; Schumann G; Kaffarnik H
    Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparison of intravenous tolbutamide and insulin administration during and after operation in patients with maturity-onset diabetes (author's transl)].
    Fähndrich W; Liebermeister H; Schmitt H; Daweke H
    Dtsch Med Wochenschr; 1974 Jan; 99(4):121-7. PubMed ID: 4203796
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of glibenclamide on non-esterified fatty acid levels in the plasma of the severely alloxan diabetic rat.
    Foy JM; Standing VF
    Experientia; 1973 Aug; 29(8):1006-8. PubMed ID: 4200262
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)].
    Baumeister G; Wagner H; Stahl M
    Klin Wochenschr; 1975 Jun; 53(12):571-4. PubMed ID: 811925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent hypoglycemia secondary to drug-dispensing error.
    Shumak SL; Corenblum B; Steiner G
    Arch Intern Med; 1991 Sep; 151(9):1877-8. PubMed ID: 1909521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 35. [Single intravenous glibenclamide-glucose loading as a prediction test (author's transl)].
    Pfeiffer EF; Raptis S; Schröder KE
    Dtsch Med Wochenschr; 1974 Jun; 99(24):1281-94. PubMed ID: 4210532
    [No Abstract]   [Full Text] [Related]  

  • 36. Chlorpropamide-induced hyponatremia: incidence and risk factors.
    Kadowaki T; Hagura R; Kajinuma H; Kuzuya N; Yoshida S
    Diabetes Care; 1983; 6(5):468-71. PubMed ID: 6443808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [EXPERIMENTAL BASIS FOR COMBINED TREATMENT OF DIABETES WITH THE BIGUANIDE-SULFONAMIDE ASSOCIATION].
    STERNE J; HIRSCH C
    Diabete; 1964; 12():171-5. PubMed ID: 14173920
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 39. An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals.
    Dunbar JC; Foà PP
    Diabetologia; 1974 Feb; 10(1):27-35. PubMed ID: 4209518
    [No Abstract]   [Full Text] [Related]  

  • 40. Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide.
    Baker IA; Jarrett RJ
    Lancet; 1972 Nov; 2(7784):945-7. PubMed ID: 4116824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.